The EMA, after analyzing approximately 150 reports, found no clear evidence of linking GLP-1 receptor agonists to increased risks of suicidal thought, or self-injurious behavior
Health consequences of shift work and insufficient sleep
This is a common reason why many people regain the weight they lost after stopping GLP-1 medications
GLP-1 is also crucial for appetite control, making it a key factor in weight management and metabolic health, both of which directly contribute to longevity
Every efficacy study (obesity, liver, muscle) used subcutaneous dosing, so injection is the route with the animal evidence behind it
If its urgent progressive condylar resorption, severe sleep apnea, an ankylosed joint, something actively getting worse the conversation is different and has to be individualized